Atara Biotherapeutics, Inc

ATRA XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

89M

Short interest (May 15)

6.4%

Net Short (Jun 03 ): -0.1%

Borrow Fee

7.37%

↓ 7.9%

Available Shares

90K

↑ 66.3%

Price Chart

Company Overview

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001604464

Asset Type: CS

Market Data

Market Cap: $89,200,702

Employees: 13

Status: Active

Short Interest

Current Borrow Fee 7.37%

Range: 7.37% - 10.37%

Available Shares 90K

Range: 45K - 90K

Recent Changes

Fee Change: ↑ 12.1%

Available Change: ↑ 6.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime